Investigating and analysing real-world population data and trends in drug utilisation
The RiPE group aims at research involving the use of real-world data to evaluate health outcomes at a population level. The RiPE group covers a broad scope of research investigating drug utilisation, prescribing trends, prescription adherence, guidelines adherence, and comparative effectiveness.
Our researchers are keen in adopting initiatives to advance pharmacoepidemiological research.
Our research group is adept at using propensity score matching, marginal structural models, and disease scores risks.
